---
figid: PMC6165994__MOL2-12-1778-g005
figlink: /pmc/articles/PMC6165994/figure/mol212369-fig-0005/
number: Figure 5
caption: (A) Nucleotide metabolism pathway. The heatmap shows the mean of the log‐transformed
  tumor/normal ratios for metabolites in AC (orange) and squamous cell cancer (blue).
  Increase (red) or decrease (green) in metabolite level. *P < 0.05, **P < 0.01 and
  ***P < 0.001. (B) PLS‐DA obtained for AC and SCC tissues using significant nucleotides
  and metabolites between normal and cancerous tissue. The datasets included those
  metabolites that were statistically significant in AC and SCC compared with normal
  tissue (37 and 61 metabolites for AC and SCC, respectively). The third PLS‐DA was
  obtained using the fold change value of each metabolite between normal and cancerous
  tissue in order to compare both types of carcinomas. For this purpose, we only considered
  those metabolites that were commonly altered in AC and SCC cases compared with normal
  tissue (34 metabolites). (C) Top 10 nucleotides and derivatives ranked by their
  discriminatory capability (expressed as mean decrease accuracy) provided by random
  forest analysis for AC and SCC cases.
pmcid: PMC6165994
papertitle: Metabolomic profiling of human lung tumor tissues – nucleotide metabolism
  as a candidate for therapeutic interventions and biomarkers.
reftext: Paula Moreno, et al. Mol Oncol. 2018 Oct;12(10):1778-1796.
pmc_ranked_result_index: '151744'
pathway_score: 0.5141216
filename: MOL2-12-1778-g005.jpg
figtitle: Nucleotide metabolism pathway
year: '2018'
organisms: Homo sapiens
ndex: 5cb0a4a1-dea2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6165994__MOL2-12-1778-g005.html
  '@type': Dataset
  description: (A) Nucleotide metabolism pathway. The heatmap shows the mean of the
    log‐transformed tumor/normal ratios for metabolites in AC (orange) and squamous
    cell cancer (blue). Increase (red) or decrease (green) in metabolite level. *P < 0.05,
    **P < 0.01 and ***P < 0.001. (B) PLS‐DA obtained for AC and SCC tissues using
    significant nucleotides and metabolites between normal and cancerous tissue. The
    datasets included those metabolites that were statistically significant in AC
    and SCC compared with normal tissue (37 and 61 metabolites for AC and SCC, respectively).
    The third PLS‐DA was obtained using the fold change value of each metabolite between
    normal and cancerous tissue in order to compare both types of carcinomas. For
    this purpose, we only considered those metabolites that were commonly altered
    in AC and SCC cases compared with normal tissue (34 metabolites). (C) Top 10 nucleotides
    and derivatives ranked by their discriminatory capability (expressed as mean decrease
    accuracy) provided by random forest analysis for AC and SCC cases.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADCY4
  - ADCY9
  - ADCY6
  - ADCY10
  - ADCY8
  - ADCY5
  - MATN1
  - ADCY7
  - ADCY3
  - EMP2
  - HEBP2
  - MFAP1
  - ADCY2
  - SERPINB3
  - BRAP
  - ADCY1
  - NT5C2
  - 5,6-dihydrouracil
  - adenine
  - Ribose-5-phosphate
  - adenosine
  - Pyrimidine
  - adenylosuccinate
  - allantoin
  - AMP
  - beta-alanine
  - Adenylosuccinate
  - GMP
  - cytidine
  - Inosine
  - Xanthosine
  - Guanosine
  - Uridine
  - Cytidine
  - Adenosine
  - guanine
  - guanosine
  - hypoxanthine
  - Adenine
  - Nupokhanthine
  - Xanthine
  - Guanine
  - inosine
  - 5,6-Dihydrouracil
  - uracil
  - uridine
  - Alantoine
  - Beta-ureidopropionic acid
  - xanthine
  - xanthosine
  - Beta-Alanine
  - 5,0-dhydrouraci
  - 2-0-methylguanosine
  - 5-Methyluridine ribothymidine
  - 5-AMP
  - Xanthosine 5'-monophosphate
  - 5,6-dihydrothymine
  - 2-AMP
  - 7-methylguanine
  - 2-deoxyinosine
  - 2-deoxyuridine
  - 5-CMP
  - N2-methylguanosine
  - Guanosine 5-diphospho-tucose
  - N6-carbamoylthrenonyladenosine
  - Hypoxanthine
  - Z
  - Adenocarcinoma
  - Squamous cell carcinoma
genes:
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: CMP
  symbol: CMP
  source: hgnc_prev_symbol
  hgnc_symbol: MATN1
  entrez: '4146'
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: XMP
  symbol: XMP
  source: hgnc_alias_symbol
  hgnc_symbol: EMP2
  entrez: '2013'
- word: (soul
  symbol: SOUL
  source: hgnc_alias_symbol
  hgnc_symbol: HEBP2
  entrez: '23593'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC/SCC
  symbol: SCC
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINB3
  entrez: '6317'
- word: IMP
  symbol: IMP
  source: hgnc_alias_symbol
  hgnc_symbol: BRAP
  entrez: '8315'
- word: AC/SCC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: GMP
  symbol: GMP
  source: hgnc_alias_symbol
  hgnc_symbol: NT5C2
  entrez: '22978'
chemicals:
- word: 5,6-dihydrouracil
  source: MESH
  identifier: C007419
- word: adenine
  source: MESH
  identifier: D000225
- word: Ribose-5-phosphate
  source: MESH
  identifier: C031626
- word: adenosine
  source: MESH
  identifier: D000241
- word: Pyrimidine
  source: MESH
  identifier: C030986
- word: adenylosuccinate
  source: MESH
  identifier: C012168
- word: allantoin
  source: MESH
  identifier: D000481
- word: AMP
  source: MESH
  identifier: D000249
- word: beta-alanine
  source: MESH
  identifier: D015091
- word: Adenylosuccinate
  source: MESH
  identifier: C012168
- word: GMP
  source: MESH
  identifier: C068152
- word: cytidine
  source: MESH
  identifier: D003562
- word: Inosine
  source: MESH
  identifier: D007288
- word: Xanthosine
  source: MESH
  identifier: C005893
- word: Guanosine
  source: MESH
  identifier: D006151
- word: Uridine
  source: MESH
  identifier: D014529
- word: Cytidine
  source: MESH
  identifier: D003562
- word: Adenosine
  source: MESH
  identifier: D000241
- word: guanine
  source: MESH
  identifier: D006147
- word: guanosine
  source: MESH
  identifier: D006151
- word: hypoxanthine
  source: MESH
  identifier: D019271
- word: Adenine
  source: MESH
  identifier: D000225
- word: Nupokhanthine
  source: ''
  identifier: ''
- word: Xanthine
  source: MESH
  identifier: D019820
- word: Guanine
  source: MESH
  identifier: D006147
- word: inosine
  source: MESH
  identifier: D007288
- word: 5,6-Dihydrouracil
  source: MESH
  identifier: C007419
- word: uracil
  source: MESH
  identifier: D014498
- word: uridine
  source: MESH
  identifier: D014529
- word: Alantoine
  source: ''
  identifier: ''
- word: Beta-ureidopropionic acid
  source: MESH
  identifier: C035122
- word: xanthine
  source: MESH
  identifier: D019820
- word: xanthosine
  source: MESH
  identifier: C005893
- word: Beta-Alanine
  source: MESH
  identifier: D015091
- word: 5,0-dhydrouraci
  source: MESH
  identifier: C016665
- word: 2-0-methylguanosine
  source: MESH
  identifier: C016578
- word: 5-Methyluridine ribothymidine
  source: MESH
  identifier: C009182
- word: 5-AMP
  source: MESH
  identifier: D000249
- word: Xanthosine 5'-monophosphate
  source: MESH
  identifier: C011141
- word: 5,6-dihydrothymine
  source: MESH
  identifier: C042836
- word: 2-AMP
  source: MESH
  identifier: D000249
- word: 7-methylguanine
  source: MESH
  identifier: C008450
- word: 2-deoxyinosine
  source: MESH
  identifier: C012271
- word: 2-deoxyuridine
  source: MESH
  identifier: D003857
- word: 5-CMP
  source: MESH
  identifier: D003568
- word: N2-methylguanosine
  source: MESH
  identifier: C016578
- word: Guanosine 5-diphospho-tucose
  source: MESH
  identifier: C017353
- word: N6-carbamoylthrenonyladenosine
  source: MESH
  identifier: D009584
- word: Hypoxanthine
  source: MESH
  identifier: D019271
- word: Z
  source: MESH
  identifier: C017788
diseases:
- word: Adenocarcinoma
  source: MESH
  identifier: D000230
- word: Squamous cell carcinoma
  source: MESH
  identifier: D002294
---
